Skip to main content

Intracranial Strokes: Mechanical Thrombectomy Using the Merci and Penumbra Devices

  • Chapter
  • First Online:
Endovascular Interventions

Abstract

The use of catheter-directed, endovascular mechanical thrombolysis has revolutionized the treatment of acute ischemic strokes in the last few years. Acute ischemic stroke remains the third most common cause of death and the first most common cause of permanent adult disability in industrialized nations. Each year, approximately 795,000 people experience a new or recurrent stroke in the USA, with its direct and indirect annual cost estimated as more than $40 billion. The only Food and Drug Administration (FDA)-approved medical therapy for acute ischemic stroke is the intravenous (IV) administration of recombinant tissue-type plasminogen activator (rtPA) within 3 h of symptom onset. The European Cooperative Acute Stroke Study (ECASS) III trial expanded the utilization of IV rtPA up to 4.5 h from symptom onset, albeit with more contraindications. Given this restricted therapeutic window, less than 1 % of acute ischemic stroke patients receive IV rtPA. Moreover, the recanalization rates of IV rtPA for proximal, large vessel occlusions range from only 10 % for internal carotid artery (ICA) occlusions to 30 % for middle cerebral artery (MCA) occlusions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ACT:

Activated coagulation time

AIS:

Acute ischemic stroke

AP:

Anteroposterior

CT:

Computed tomographic

ECASS:

European Cooperative Acute Stroke Study

FDA:

Food and Drug Administration

F:

French

ICA:

Internal carotid artery

IMS:

Interventional Management of Stroke

IV:

Intravenous

MCA:

Middle cerebral artery

MERCI:

Mechanical Embolus Removal in Cerebral Ischemia

mRS:

Modified Rankin Scale

NIHSS:

National Institutes of Health Stroke Scale

POST:

Post-market experience of the Penumbra system trial

PTT:

Partial thromboplastin time

rtPA:

Recombinant tissue-type plasminogen activator

SARIS:

Stent-Assisted Recanalization in acute ischemic Stroke

TIMI:

Thrombolysis in Myocardial Infarction

References

  1. Report of the WHO Task Force on Stroke and other Cerebrovas­cular Disorders. Stroke – 1989. Recommendations on stroke ­prevention, diagnosis, and therapy. Stroke. 1989;20:1407–31.

    Google Scholar 

  2. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation. 2012;125:e2–220.

    Article  PubMed  Google Scholar 

  3. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.

    Google Scholar 

  4. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–29.

    Article  PubMed  CAS  Google Scholar 

  5. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology. 2001;56:1015–20.

    Article  PubMed  CAS  Google Scholar 

  6. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol. 1993;14:3–13.

    PubMed  CAS  Google Scholar 

  7. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke. 1998;29:4–11.

    Article  PubMed  Google Scholar 

  8. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003–11.

    Article  PubMed  CAS  Google Scholar 

  9. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 2005;36:1432–8.

    Article  PubMed  Google Scholar 

  10. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008;39:1205–12.

    Article  PubMed  Google Scholar 

  11. IMS Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke. 2004;35:904–11.

    Article  Google Scholar 

  12. IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke. 2007;38:2127–35.

    Article  Google Scholar 

  13. Tomsick T, Broderick J, Carrozella J, Khatri P, Hill M, Palesch Y, et al. Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol. 2008;29:582–7.

    Article  PubMed  CAS  Google Scholar 

  14. Brott T, Adams Jr HP, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864–70.

    Article  PubMed  CAS  Google Scholar 

  15. TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985;312:932–6.

    Google Scholar 

  16. Zaidat OO, Wolfe T, Hussain SI, Lynch JR, Gupta R, Delap J, et al. Interventional acute ischemic stroke therapy with intracranial self-expanding stent. Stroke. 2008;39:2392–5.

    Article  PubMed  Google Scholar 

  17. Levy EI, Siddiqui AH, Crumlish A, Snyder KV, Hauck EF, Fiorella DJ, et al. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke. 2009;40:3552–6.

    Article  PubMed  Google Scholar 

  18. Gralla J, Schroth G, Remonda L, Nedeltchev K, Slotboom J, Brekenfeld C. Mechanical thrombectomy for acute ischemic stroke: thrombus-device interaction, efficiency, and complications in vivo. Stroke. 2006;37:3019–24.

    Article  PubMed  Google Scholar 

  19. Tarr R, Hsu D, Kulcsar Z, Bonvin C, Rufenacht D, Alfke K, et al. The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe. J Neurointerv Surg. 2010;2:341–4.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Eller, J.L., Hopkins, L.N., Levy, E.I. (2014). Intracranial Strokes: Mechanical Thrombectomy Using the Merci and Penumbra Devices. In: Dieter, R., Dieter, Jr., R., Dieter, III, R. (eds) Endovascular Interventions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7312-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7312-1_1

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7311-4

  • Online ISBN: 978-1-4614-7312-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics